These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16919875

  • 1. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
    Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA.
    Neurosci Lett; 2006 Oct 09; 406(3):189-93. PubMed ID: 16919875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
    Liu G, Men P, Kudo W, Perry G, Smith MA.
    Neurosci Lett; 2009 May 22; 455(3):187-90. PubMed ID: 19429118
    [Abstract] [Full Text] [Related]

  • 5. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD, Evans RW, Evans PJ, Hider RC.
    Biochem J; 2008 Jan 15; 409(2):439-47. PubMed ID: 17919118
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease.
    Gaeta A, Molina-Holgado F, Kong XL, Salvage S, Fakih S, Francis PT, Williams RJ, Hider RC.
    Bioorg Med Chem; 2011 Feb 01; 19(3):1285-97. PubMed ID: 21236688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P, Mackova E, Haskova P, Vavrova A, Jirkovsky E, Sterba M, Popelova O, Kalinowski DS, Kovarikova P, Vavrova K, Richardson DR, Simunek T.
    Chem Res Toxicol; 2010 Jun 21; 23(6):1105-14. PubMed ID: 20521781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of iron in neurodegenerative disorders.
    Berg D, Youdim MB.
    Top Magn Reson Imaging; 2006 Feb 21; 17(1):5-17. PubMed ID: 17179893
    [Abstract] [Full Text] [Related]

  • 11. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M, Richardson DR.
    Semin Pediatr Neurol; 2006 Sep 21; 13(3):186-97. PubMed ID: 17101458
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron chelators can protect against oxidative stress through ferryl heme reduction.
    Reeder BJ, Hider RC, Wilson MT.
    Free Radic Biol Med; 2008 Feb 01; 44(3):264-73. PubMed ID: 18215735
    [Abstract] [Full Text] [Related]

  • 14. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
    Mandel S, Amit T, Bar-Am O, Youdim MB.
    Prog Neurobiol; 2007 Aug 01; 82(6):348-60. PubMed ID: 17659826
    [Abstract] [Full Text] [Related]

  • 15. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK, Kalinowski DS, Richardson DR.
    Mol Pharmacol; 2008 Jul 01; 74(1):225-35. PubMed ID: 18424550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
    Gama S, Gil M, Gano L, Farkas E, Amélia Santos M.
    J Inorg Biochem; 2009 Feb 01; 103(2):288-98. PubMed ID: 19091421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities.
    Blat D, Weiner L, Youdim MB, Fridkin M.
    J Med Chem; 2008 Jan 10; 51(1):126-34. PubMed ID: 18078312
    [Abstract] [Full Text] [Related]

  • 20. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ.
    Mol Pharmacol; 1986 Dec 10; 30(6):670-3. PubMed ID: 3785144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.